1. Hospitalisation costs of primary liver cancer in Australia: evidence from a data-linkage study.
- Author
-
Nguyen, Anh Le Tuan, Blizzard, Christopher Leigh, Yee, Kwang Chien, Campbell, Julie A., Palmer, Andrew J., and de Graaff, Barbara
- Subjects
MEDICAL care cost statistics ,BIRTHPLACES ,LIVER tumors ,SCIENTIFIC observation ,HOSPITAL emergency services ,TIME ,AGE distribution ,CHOLANGIOCARCINOMA ,MEDICAL care costs ,RETROSPECTIVE studies ,POPULATION geography ,REGRESSION analysis ,CANCER patients ,URBAN hospitals ,COMPARATIVE studies ,HOSPITAL care ,PUBLIC hospitals ,DESCRIPTIVE statistics ,SYMPTOMS ,EMERGENCY medical services ,INFORMATION retrieval ,COST analysis ,SURVIVAL analysis (Biometry) ,SOCIODEMOGRAPHIC factors ,DATA analysis software ,CANCER patient medical care ,LONGITUDINAL method ,HEPATOCELLULAR carcinoma - Abstract
Objective: This study aimed to estimate the public hospital costs associated with primary liver cancer (PLC) in the first and second years following the cancer diagnosis. Methods: This study linked administrative datasets of patients diagnosed with PLC in Victoria, Australia, from January 2008 to December 2015. The health system perspective was adopted to estimate the direct healthcare costs associated with PLC, based on inpatient and emergency costs. Costs were estimated for the first 12 months and 12–24 months after the PLC diagnosis and expressed in 2017 Australian dollars (A$). The cost estimated was then extrapolated nationally. The linear mixed model with a Box–Cox transformation of the costs was used to explore the relationship between costs and patients' sociodemographic and clinical characteristics. Results: For the first 12 months, the total and annual per-patient cost was A$211.4 million and A$63 664, respectively. Costs for the subsequent year were A$49.7 million and A$46 751, respectively. Regarding the cost extrapolation to Australia, the total cost was A$137 million for the first 12 months after notification and A$42.6 million for the period from 12 to 24 months. Higher costs per episode of care were mostly associated with older age, hepatocellular carcinoma type of PLC, metropolitan hospitals, and Asian birth region. Conclusion: This study showed the public hospital admission and emergency costs associated with PLC and the substantial economic burden this cancer has placed on the Australian health system. What is known about the topic? There are limited data on the economic burden of primary liver cancer in Australia. What does this paper add? This study showed the cost in the second year after cancer diagnosis was substantially lower than that of the first year. Higher costs per episode of care were mostly associated with older age, metropolitan hospitals, and Asian birth region. What are the implications for practitioners? Results from this study can be used as a baseline for comparison with other initiatives to mitigate cancer risk factors or inputs for future economic evaluations of cancer surveillance. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF